Young Woman with Rare, Life-Threatening Vascular Spread of Kidney Cancer Successfully Treated at Apollo Hospitals Chennai

Chennai, 28 April 2026: Young Woman with Rare, Life-Threatening Vascular Spread of Kidney Cancer Successfully Treated at Apollo Hospitals Chennai

Complex vascular involvement across major veins addressed through advanced surgery with focus on organ preservation and recovery.

 Apollo Speciality Hospitals, Vanagaram, Chennai, has successfully treated a rare and complex case of advanced kidney cancer in a 30-year-old woman, where the tumour had extended into major blood vessels, including the inferior vena cava (IVC) and both the right and left renal veins.

The patient complained of having a dull pain in the flanks and was examined by a general physician. An ultrasound was recommended which led to the identification of the condition. The clinical evaluation revealed right kidney cancer with tumour thrombus extending into the IVC, a large vein that carries blood from the lower body to the heart, and, unusually, involvement of both renal veins. This pattern of spread is extremely rare and presents significant surgical and clinical challenges.

A multidisciplinary team led by Dr. Antan Uresh Kumar T, Senior Consultant, Urology, undertook a highly complex surgery lasting nearly eight hours. The procedure involved removal of the affected right kidney along with meticulous clearance of tumour from the IVC and both renal veins, while preserving the function and integrity of the left kidney.

“This was a highly complex case because the tumour had extended into the inferior vena cava as well as both renal veins, which is extremely uncommon. The key challenge was to achieve complete tumour clearance while preserving the function of the unaffected kidney. Such cases require careful planning and close coordination across specialties. The patient’s recovery and stability post-surgery are encouraging, and she continues to be under structured follow-up and treatment,” said Dr. Antan Uresh Kumar T, Senior Consultant, Urology.

The involvement of both renal veins alongside the IVC makes this case particularly uncommon, especially in the context of a Ewing’s sarcoma variant of kidney cancer. Managing such extensive vascular involvement requires close coordination across specialties and precise intraoperative decision-making to balance complete tumour removal with organ preservation.

“Cases like these highlight how kidney cancers can sometimes progress silently until they involve critical vascular structures. Early evaluation of symptoms such as persistent flank pain or unexplained swelling is important. At the same time, the ability to manage such complex presentations through a multidisciplinary approach is central to improving outcomes in advanced cancers,” he added.

The surgery was performed with support from a multidisciplinary team including Dr. Jayakrishnan, Senior Consultant, Vascular Surgery; Dr. Nikhil, Senior Consultant, CTVS; Dr. Suresh, Senior Consultant, Medical Oncology; Dr. Mohanakrishnan, Consultant, Pulmonology; Dr. Ravikumar, Senior Consultant, Nephrology; and Dr. Muthukumaran, Senior Consultant, Medical Gastroenterology.

Following surgery, the patient had a stable recovery and was discharged within a week. She is currently undergoing chemotherapy and continues to be under close clinical follow-up.

This case represents an exceptionally rare presentation of kidney cancer with involvement of both renal veins and the IVC, successfully managed through a multidisciplinary approach, with a focus on both oncological control and organ preservation.

About Apollo Hospitals

Apollo revolutionised healthcare when Dr. Prathap Reddy opened the first hospital in Chennai in 1983. Today, Apollo is the world’s largest integrated healthcare platform with over 10,400 beds across 76 hospitals, 6,600+ pharmacies, 264 clinics, 2,182 diagnostic centres, and 800+ telemedicine centres. It is one of the world’s leading cardiac centers, having performed over 3,00,000 angioplasties and 2,00,000 surgeries. Apollo continues to invest in research and innovation to bring the most cutting-edge technologies, equipment, and treatment protocols to ensure patients have access to the best care in the world. Apollo’s 1,20,000 family members are dedicated to delivering exceptional care and leaving the world better than we found it.